Cargando…
Sirolimus and Other Mechanistic Target of Rapamycin Inhibitors Directly Activate Latent Pathogenic Human Polyomavirus Replication
BACKGROUND: Human polyomaviruses can reactivate in transplant patients, causing nephropathy, progressive multifocal leukoencephalopathy, Merkel cell carcinoma, pruritic, rash or trichodysplasia spinulosa. Sirolimus and related mechanistic target of rapamycin (mTOR) inhibitors are transplant immunosu...
Autores principales: | Alvarez Orellana, Jennifer, Kwun, Hyun Jin, Artusi, Sara, Chang, Yuan, Moore, Patrick S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514189/ https://www.ncbi.nlm.nih.gov/pubmed/32060513 http://dx.doi.org/10.1093/infdis/jiaa071 |
Ejemplares similares
-
Molecular Characterization of BK Polyomavirus Replication in Allogeneic Hematopoietic Cell Transplantation Patients
por: Leuzinger, Karoline, et al.
Publicado: (2022) -
Topical rapamycin (sirolimus) for facial angiofibromas
por: Madke, Bhushan
Publicado: (2013) -
Cellular and Viral Factors Regulating Merkel Cell Polyomavirus Replication
por: Feng, Huichen, et al.
Publicado: (2011) -
In vitro assessment of the combined effect of letermovir and sirolimus on cytomegalovirus replication
por: Giménez, Estela, et al.
Publicado: (2023) -
Source and Relevance of the BK Polyomavirus Genotype for Infection After Kidney Transplantation
por: Wunderink, H F, et al.
Publicado: (2019)